VIDEO: EyePoint to launch two new products in first quarter

WAIKOLOA, Hawaii — Nancy Lurker, CEO of EyePoint Pharmaceuticals, discusses the planned launch of Yutiq (fluocinolone acetonide intravitreal implant 0.18 mg) for posterior segment uveitis and Dexycu (dexamethasone injectable suspension 9%) for postoperative inflammation following cataract surgery here at Hawaiian Eye 2019.

Full Story →